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A paucity of antenatal alcohol consumption prevalence rates in the UK and limited guidance around 
the implementation of antenatal screening practices led to the inception of my research within the 
field. In particular, the need to raise awareness of the risks of Prenatal Alcohol Exposure (PAE) and 
FASD with UK health professionals and the wider public. As a midwife researcher I identified that 
addressing this gap in knowledge was urgently required to evaluate and improve antenatal alcohol 
practices and services.   
 
Introduction 
My published papers follow a logical and sustained sequence of investigations to address this deficit, 
and consequently make an independent and original contribution to knowledge and understanding. 
Adopting an inductive approach, I initially examined the utility of self-report in relation to blood 
biomarkers to improve existing screening methods. Expanding the scope of my research to examine 
patient and healthcare professional’s expectations, knowledge and experience in relation to alcohol 
in pregnancy and the condition of Fetal Alcohol Spectrum Disorder (FASD). Finally, I consolidated 
this work by evaluating existing practices and services across the North-east and North Cumbria to 









The aim of my PhD was to investigate the feasibility and clinical effectiveness of antenatal alcohol 
screening for pregnant women, their partners and clinicians; and to evaluate a regional antenatal 
alcohol service provision in maternity practice. 
 
Design and Methodology 
 
I have taken a pragmatic approach and utilised a variety of methods to fully address my research 
objectives. A systematic review was undertaken comparing the diagnostic accuracy of blood 
biomarker analysis to maternal self-report in the detection of antenatal alcohol consumption. 
Retrospective anonymous surveillance using clinical audit methodology and blood biomarker 
analysis was employed to obtain epidemiological prevalence data regarding antenatal alcohol use. 
Surveys were used to understand patient understanding and attitudes to antenatal alcohol screening 
and healthcare professionals’ knowledge and experience of alcohol and FASD in practice. An 
evaluation of current alcohol prevention, screening and treatment service provision in maternity care 
practices and services in the North East and North Cumbria using content analysis was undertaken to 
inform strategic planning for the Local Maternity System. 
 
Results 
The six publications present a logical and inductive progression of enquiry, culminating in the 
presentation of a body of evidence which validates antenatal alcohol screening as feasible, acceptable 
and a recognised public health priority which should be integral to routine clinical practice. 
However, the effectiveness of the screening methods varied, and more research is required into blood 





healthcare professionals and the public. In response, the prioritisation of antenatal alcohol screening 
and the standardisation of best practices are recognised needs in UK maternity services. As a 
measure of success, I have received national and local recognition of my research which is now 




My main knowledge contributions are: 
 
• Production of empirical evidence that antenatal alcohol screening can effectively identify 
women at risk, thereby facilitating intervention to improve both maternal and infant health 
outcomes 
 
• The demonstrated feasibility and acceptability of establishing routine antenatal alcohol 
screening also has the potential to determine reliable UK alcohol in pregnancy prevalence 
rates to inform future healthcare strategies.  
 
• Self-report is the cheapest and most accessible method of screening, but blood biomarkers 
may also be beneficial and cost-effective in the long-term.  
 
• FASD and alcohol in pregnancy training is urgently required for UK healthcare 






• Alcohol reduction in pregnancy should be made an urgent public health priority in UK 
maternity services to improve health outcomes across the life-course.  
 
• Standardised UK patient pathways involving alcohol screening and management practices 
are required, and the sharing of best practices will facilitate referrals and support 
regardless of location.  
 
• The implementation of these recommendations requires appropriate leadership, 




My research has helped raised awareness and improved current practices relating to alcohol in 
pregnancy in the UK. The findings include original regional prevalence rates and have identified 
potential antenatal alcohol screening and management strategies. My evidence-based 
recommendations are already informing national Public Health England recommendations, NICE 
consultations, multidisciplinary training and service improvement initiatives. This new evidence has 
demonstrated the need for further inquiry into the challenging and complex issues surrounding 
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Glossary of Terms 
 
ADHD  Attention Deficit Hyperactivity Disorder 
ALT Alanine Aminotransferase 
ARBD    Alcohol Related Birth Defects 
APPG All Party Parliamentary Group 
ARND    Alcohol Related Neurodevelopmental Disorders 
AST Aspartate Aminotransferase  
AUDIT Alcohol Use Disorder Identification Test 
Audit-C Alcohol Use Disorders Identification Test-Concise 
BMI Body Mass Index  
CAGE Alcohol use questionnaire with four items: Cut down, Annoyed, Guilt, 
Eye-opener 
CDT Carbohydrate-Deficient Transferrin 
CNS      Central Nervous System 
CI  Confidence Interval 
CMO  Chief Medical Officer 
CNS  Central Nervous System 
CRN Clinical Research Network 
DH        Department of Health 
DSM-5  Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) 
EtG  Ethyl Glucuronide 
EU        European Union 
FAEE  Fatty Acid Ethyl Ester 
FASD    Fetal Alcohol Spectrum Disorders 
FAS     Fetal Alcohol Syndrome 
FAST   Fast Alcohol Screening Test 
GGT Gamma-Glutamyl Transferase 
GP    General Practitioner 
IRAS Integrated Research Application System  
LMS Local Maternity System 
MCV Mean Corpuscular Volume 
ND-PAE      Neuro-behavioural Disorder associated with Prenatal Alcohol Exposure 
NEQAS National External Quality Assessment Service 
NHCT Northumbria Healthcare Foundation NHS Trust 
NHS  National Health Service 
NIAAA  National Institute on Alcohol Abuse and Alcoholism 
NICE    National Institute for Health and Care Excellence 
NIHR National Institute of Health Research 
NPEU   National Perinatal Epidemiology Unit 
NO-FAS  National Organisation for Fetal Alcohol Syndrome 
NTHFT North Tees and Hartlepool NHS Foundation Trust  
ONS    Office for National Statistics 
PAE      Prenatal Alcohol Exposure 
PEth  Phosphatidyl ethanol 





PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
QUADAS-2  Quality Assessment of Diagnostic Accuracy Studies 
RCOG    Royal College of Obstetricians and Gynaecologists 
RfPB Research for Public Benefit 
SPSS Statistical Package for the Social Sciences 
T-ACE Alcohol use questionnaire with four items: Tolerance, Annoyance, Cut 
down, Eye opener  
TLFB Timeline Follow-Back procedure  
TWEAK Alcohol use questionnaire with five items: Tolerance, Worried, Eye-
opener, Amnesia and K/Cut down 
UK  United Kingdom 
USA United States of America 
WBAA Whole Blood Associated Acetaldehyde  
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1. Chapter One – Introduction 
 
This chapter sets the scene for my PhD by providing an overview of the epistemological and 
philosophical position of my work; what originally initiated the research and what has maintained the 
momentum to complete it. The research presented in this PhD by doctoral works is based on six 
sequential studies that make a coherent and significant contribution to knowledge, validating the 
importance and feasibility of antenatal alcohol screening to improve maternal and infant outcomes in 
the United Kingdom (UK). The impact of this research culminated in a regional evaluation of antenatal 
alcohol service provision with the recommendations implemented to change clinical practice and 
service provision. The research was undertaken part-time from 2014 to 2020 whilst the author worked 
for Northumbria Healthcare Foundation NHS Trust (NHCT), as a full-time Senior Research Nurse and 
Midwife.  
1.1. Philosophical and epistemological position of my published papers 
 
My special interest in Fetal Alcohol Spectrum Disorder (FASD) began in 2012 when I attended a 
FASD training session and met a mother speaking candidly about the daily challenges she experienced 
parenting her daughter who had extensive neurodevelopmental disabilities caused entirely by Prenatal 
Alcohol Exposure (PAE). Until this point, I had not realised the enormity of problems that can arise 
as a result of PAE and FASD. This issue was not addressed or even acknowledged by most UK health 
care professionals. Social services, education and the judicial system were inevitably burdened with 
the challenges of FASD, although understandably unaware because these complex individuals 
remained undiagnosed and therefore invisible. Furthermore, without robust evidence, policy makers 
in Public Health and Government had no inducement to act; and without prevalence data, research was 





To place the magnitude of FASD in context, the NHS spent £30 million in 2013 to screen and diagnose 
for Down’s syndrome, which affects approximately 0.1% of pregnancies, yet there was no allocated 
budget for alcohol screening in pregnancy which was estimated to impact upon 1-5% of pregnancies 
(Taylor, 2013; Morleo et al., 2011). This incurable but avoidable disability was not on the UK health 
prevention agenda and antenatal alcohol screening in pregnancy was not routine practice, so children 
were rarely diagnosed with FASD preventing access to essential services and interventions.  Having 
listened to the expressed need for change from families living with FASD, the extent of this public 
health inequality motivated my subsequent research (FASD Network UK, 2019; NOFAS-UK, 2018).  
My professional discipline as a midwife researcher draws upon qualitative paradigms as the woman-
centred approach is fundamental, aligning to the subjective interactive perspective of the individual 
whereby reality is constructed in the interpretivist paradigm. Feminism frames the midwifery 
profession and by adopting feminist approaches we can fully appreciate and explore the intricate 
relationship between women, alcohol and FASD which has traditionally incurred judgement and 
hostility from the media, highlighting the unjust gender inequalities that still persist today (Corrigan 
et al., 2017; Scambler, 2018). Paradoxically, the positivist paradigm is also intrinsic to midwifery 
practice, as the medically led, obstetric and gynaecological domains of knowledge also underpin 
midwifery. Evidence derived from quantitative results; measurable and generalisable, predominantly 
influence practice and legislation. As a midwife, working in clinical trials, I was adept and experienced 
in both paradigms.  
In response to these complex dynamics, which reflect the epistemological art or science debate of 
midwifery, I adopted a pragmatic paradigm of inquiry, guided by the knowledge gaps and emerging 
research questions (Power, 2015). From my professional position, the logical course was to examine 





and pregnancy. Therefore, my early research focus was to generate quantifiable prevalence data 
regarding alcohol exposed pregnancies to facilitate and implement targeted solutions. My subsequent 
research developed organically as my knowledge of the area deepened and my networks and area of 
influence in the subject field expanded. Combined, my research has contributed to regional, national, 
and international developments within the field of antenatal alcohol screening and management. It has 
also informed national policy in the UK and made a positive contribution to clinical practice, maternity 
















Chapter 2: Framework of understanding for FASD  
  
2.1 Background to FASD 
 
 
FASD is noted as the leading known cause of preventable non-genetic learning disability in the 
Western world (Poole et al., 2016; Stratton, Howe and Battaglia, 1996). This astonishing statistic and 
the ability to avert the harm resonated with my personal sense of injustice and galvanised my 
preliminary investigations. FASD is an umbrella term relating to a broad spectrum of intellectual and 
developmental deficits in individuals, resulting from PAE. Alcohol is fetotoxic and teratogenic (i.e. a 
substance which interferes with the normal development of the embryo or fetus) and freely crosses the 
placenta (Mukherjee et al., 2005). In the absence of a developed blood filtration system, the fetus is 
unprotected from alcohol circulating in the blood stream and damage to any organ in the body can 
result (British Medical Association, 2016). Hepper (2012) conducted research using ultrasound 
monitoring of fetal behaviour and observed that when mothers consumed just one unit of alcohol, fetal 
activity ceased for up to two hours (Hepper, Dornan and Lynch, 2012). Hepper (2012) also concluded 
that the liquor in the uterus acts as a reservoir for alcohol that is recirculated through the fetus many 
times before eventually returning to the mother to be metabolised and excreted (Hepper et al., 2012).  
 
FASD is associated with a range of physical and intellectual disabilities including small stature, organ 
damage, hearing and vision impairments (May et al., 2013a). However, only 10% of children with 
FASD present with the distinctive facial dysmorphia, including a small head, small eyes, thin upper 
lip and a smooth philtrum. The lack of distinctive physical features make diagnosis more difficult and 
it is often referred to as a ‘hidden’ disability (Walker, Edwards and Herrington, 2016). Damage to the 
brain for all children with FASD can result in developmental disabilities including general learning 





consequential thinking and reduced planning ability (Streissguth and Kanter, 1997; Andrews et al., 
2018). This illustrates how FASD is an enduring and significant public health concern. 
 
2.2 Risk factors of FASD 
 
 
FASD is linked to heavy alcohol intake during pregnancy, but not all babies exposed to high levels of 
alcohol are affected (Ceccanti et al., 2014). Binge drinking, defined as exceeding six units in one day, 
has been identified as the greatest risk to the fetus, but the safety of low to moderate levels of PAE 
have yet to be evidenced (Maier and West, 2001). The severity of alcohol harm to a fetus primarily 
depends on three risk factors: the quantity of alcohol a pregnant woman drinks on each occasion; the 
frequency of drinking episodes and the gestation of her pregnancy (May and Gossage, 2011; May et 
al., 2013a).  
 
Specific maternal characteristics also influence how children can be affected by PAE (May and 
Gossage, 2011). Mothers who are poorly nourished; have had multiple pregnancies and births; are 
lower-than-average weight, height, and body mass index (BMI); who smoke or engage in polydrug 
use; are older and who come from a family of heavy drinkers, are more likely to be adversely affected 
(May and Gossage, 2011; Ceccanti et al., 2014). Environmental factors also predispose children 
affected by PAE if their mothers experience adverse-living conditions and high levels of stress (May 
et al., 2013b). Examples include social isolation, living in communities with limited antenatal care or 
in circumstances where excessive drinking is common and accepted (May and Gossage, 2011). These 
complex social, economic and health related factors relating to PAE are commonly encountered by the 
midwife delivering antenatal care but due to low levels of awareness, this issue was not routinely 





2.3 Living with FASD 
 
Individuals with FASD face daily challenges that may include understanding and following directions; 
focusing their attention; controlling emotions and impulses; communicating, socialising, and 
performing daily life skills such as, feeding, bathing, counting money, telling the time, and personal 
safety awareness. FASD-related brain damage also inhibits the processing of routine life situations and 
can cause children and adults to make bad decisions, repeat the same mistakes, trust the wrong people 
and impedes their understanding and prediction of consequences to their actions (Catterick and Curran, 
2014; Flak et al., 2014; Public Health England, 2016b; Streissguth and Kanter, 1997). Consequently, 
children who suffer from FASD can be difficult to manage, are more likely to be taken into the care 
system and come into contact with the criminal justice system (Streissguth and Kanter, 1997; NOFAS-
UK; NIAAA, 2015). Furthermore, people with FASD are more likely to suffer from mental health 
disorders including Attention Deficit Hyperactivity Disorder (ADHD); depression and anxiety; 
problems with hyperactivity, conduct and impulse control; and poignantly an increased incidence of 
alcohol and substance misuse disorders. These factors place a huge emotional, physical and fiscal 
burden on their families, the health service, social care, education and the judiciary system (Stade et 
al., 2009; Catterick and Curran, 2014). Consequently, research to reduce this impact and ensure early 
intervention is key. 
2.4 Prevalence rates of FASD 
 
Internationally, the prevalence rate of FASD is commonly represented as 1% (NIAAA, 2015). 
Previously the prevalence of FASD within the UK was estimated to be 1-2%, a conservative estimate 
due to incomplete datasets; limited data intelligence systems and low practitioner awareness and 
specialist expertise (Morleo et al., 2011; Harwin, 2010; Blackburn, Carpenter and Egerton, 2009; 





the UK ranges from 6% to 17% (McQuire et al., 2019). Given the disparity in figures and lack of 
current epidemiological data, contemporary research in this field was paramount.  
2.5 FASD Economic impact 
 
 
The human costs of pain, suffering and stress associated with the numerous disabilities of individuals 
and families living with FASD are difficult to quantify. The financial burden of FASD has not yet been 
officially measured in the UK, but a Canadian cost analysis which included the health, educational and 
social care needs of children with FASD in 2013 calculated an astounding $1.8 billion total per year 
(Popova et al., 2016). Children born with FASD are referred to internationally as one million dollar 
babies due to the life‐time costs posed by the condition (Thanh and Jonsson, 2009). At a conservative 
1% prevalence, of the 679,106 live births in England and Wales in 2017, 67911 of these children would 
have FASD (ONS, 2018b). In the UK, even a modest 1% prevalence rate would cost almost £68 billion 
for children born in 2017 alone. If UK FASD prevalence rates are nearer 17%, this bill could be 
multiplied seventeen times. This colossal expense can be argued to justify the cost effectiveness of 
preventative antenatal alcohol screening and interventions. In addition, Public Health England (2016) 
estimated the cost of alcohol consumption to the NHS alone to be in excess of £3.5 million pounds per 
year, contributing to an overall annual cost to society of £21 billion (Public Health England, 2016b). 
Therefore, by generating empirical data on antenatal alcohol prevalence rates I set out to inform the 
debate and influence future policy.  
 
This chapter has provided a framework of understanding regarding the symptoms and impact of FASD, 











As a reflexive practitioner, I recognise that my research has been shaped by a variety of social and 
feminist paradigms which influence the likelihood of FASD and cause complexity and confusion for 
women and their partners. Therefore, it was imperative my research explored why alcohol harms 
should be addressed at society level rather than burdening individuals with blame. This is an important 
concept because stigma associated with women, alcohol and FASD can be a significant barrier to care 
access and provision (Corrigan et al., 2017).  
 
Alcohol pervades all social classes in the UK and interestingly, hazardous levels of alcohol 
consumption are more common in the highest income households (22%) compared to the lowest (13%) 
(Department of Health, 2016). Women from managerial and professional socio-economic groups drink 
more on average than female routine and manual workers or women who were unemployed (Office 
for National Statistics, 2018). One explanation for this is that women may have more opportunity for 
corporate drinking than previous generations due to changes in attitude and behaviour regarding 
alcohol, combined with a culture of drinking to excess in some workplace settings (Romo, Dinsmore 
and Davis, 2015).  
 
One study reported that women who were more educated, were more likely to frequently drink alcohol 
and admit to their drinking problem (Borgonovi and Huerta, 2010). Although we are progressing to an 
international consensus recommending total abstinence in pregnancy; societal influences and personal 
experience remain powerful influences (Schölin, 2016). Alcohol is an embedded element of UK 





(Department of Health, 2016). Alcohol is comparatively cheaper than ever before, more readily 
available and socially acceptable; and therefore is not generally perceived to be harmful (Public Health 
England, 2016b). An appreciation of cultural context is an important step to understanding why women 
drink in pregnancy and informed the exploration of potential management strategies.  
 
3.2 Alcohol harms and trends 
 
 
Alcohol consumption is associated with co-morbidities including injury, cardiovascular disease and 
many cancers (Department of Health, 2016). Alcohol misuse can also originate from and trigger mental 
health problems (Alcohol Concern and Alcohol Research UK, 2018). Sadly, alcohol-specific deaths 
among women reached the highest on record in 2017 at 8.0 deaths per 100,000 females (ONS, 2018a). 
High alcohol consumption trends in women of childbearing age increases women’s risk of having a 
child affected by PAE (Mukherjee, Hollins and Turk, 2006). To illustrate this, the Office for National 
Statistics (ONS) found that ‘binge drinking’ or ‘heavy episodic drinking’ which equates to six or more 
units per session, remains highest in the age groups 16-24 year olds (42%) and 25-44 year olds (35.6%) 
(ONS, 2017). In the early 1990’s the media coined the somewhat derogatory term 'ladette' to reflect 
this UK-wide phenomenon of young women who “behave in a boisterously assertive or crude manner 
and engage in heavy drinking sessions” (Oxford Dictionary, 2018). The significant public health risk 









3.3 Alcohol in pregnancy prevalence rates 
 
 
Although most women avoid alcohol during pregnancy, 25–50% of European women continue to drink 
alcohol and some to high levels (Gray and Henderson, 2006). This may be partially attributed to the 
fact that approximately half of UK pregnancies are unplanned, and many women unwittingly consume 
alcohol before pregnancy confirmation (Morleo et al., 2011). This necessitates research examining the 
impact of counselling women who realise that they were drinking around the time of conception and 
early pregnancy. The UK Infant Feeding Survey (2010) identified that 40% of mothers consumed 
alcohol in pregnancy (McAndrew et al., 2012). This survey was not distributed by doctors or midwives 
and therefore women may be more comfortable giving a truthful, anonymous responses thus increasing 
reliability. This was corroborated with a 41.3% prevalence rate in 2018, placing the UK in the global 
top four highest consumers of alcohol during pregnancy (Popova et al., 2018). These studies 
substantiated the urgent need to determine accurate UK prevalence data and to establish a national, 
routine antenatal alcohol screening strategy. This palpable gap in knowledge and clinical practice 
guided my research aims and objectives.       
 
3.4 Official guidelines 
 
 
Although pregnant women in England should receive information about the risks of alcohol harm from 
their midwives at the booking appointment at 8-12 weeks, for reasons unknown, this assumed approach 
appears to have limited impact on their drinking behaviour. Evidence shows that approximately two 
fifths of women drink alcohol when pregnant (McAndrew et al., 2012; McQuire et al., 2019). The 






The ostensible dissonance between the evidence of PAE associated harms and the perpetuated high 
drinking behaviours in pregnancy may be somewhat explained by the unclear and sometimes 
contradictory messages that women receive from health professionals (Schölin, 2019). A range of 
contradictory guidelines and advice from various professional bodies were in the public domain in 
2014. These discrepancies and the clear lack of evidence contributed to inconsistent clinical 
interventions and underpinned my research which aimed to inform, improve and standardise best 
practice. For example, the National Institute for Clinical Excellence (NICE) (2008) based their 
recommendations on the Royal College of Obstetricians and Gynaecologists (RCOG) guidelines 
(2008, updated 2015), which stated that women could drink 1-2 units of alcohol 1-2 times per week 
following the first trimester of pregnancy (NICE, 2008a; RCOG, 2018). This information was based 
primarily on evidence linking alcohol in early pregnancy with the increased incidence of miscarriage, 
premature birth and low birth weight (NICE, 2008a; Nykjaer et al., 2014). Advice which conflicted 
with international evidence-informed guidelines, including the British Medical Association (BMA) 
(2007), who clearly stated that abstinence is the only safe policy for women who are pregnant or 
planning a pregnancy (British Medical Association, 2007; Parliament, 2012; Scottish Government 
Consultation, 2012). 
 
It was also notable that England lagged behind the public health messages of a number of developed 
countries including France, Germany, Canada and Australia who explicitly recommended alcohol 
abstinence throughout pregnancy to prevent the risk of FASD (British Medical Association, 2007). 
Indeed as far back as 1981 United States of America (USA) recommended complete abstinence in 
pregnancy due to the expanding body of evidence highlighting the risks of harm from PAE and lack 
of information regarding any ‘safe’ amounts of alcohol consumption in pregnancy (Warren, Hewitt 





general agreement that women should not drink excessively during pregnancy, the level of drinking 
harmful to a pregnant woman and her baby remained unclear, concluding insufficient evidence to 
recommend total abstinence (NICE, 2008b).  
 
The Chief Medical Officer (CMO) guidelines were eventually updated in January 2016, in response to 
the unavoidable growing evidence supporting a more ‘precautionary’ approach (Department of Health, 
2016). In August 2016, the NICE Antenatal Care Guidelines followed suit and referred women to the 
CMO guidelines which now advised abstinence from alcohol in pregnancy or when planning a 
pregnancy, to minimise the risks of harm (Department of Health, 2016). However, evidence suggests 
that these new guidelines were not adequately promoted to professionals or the public, resulting in 
continued lack of awareness and poor compliance, again reinforcing the importance of my research 
objectives (Schölin, 2019). Specifically, professional perspective data were warranted to explore local 
and national attitudes and identify gaps in practice.       
 
3.5 Units of alcohol  
 
 
Women in the UK are known to have a generally poor understanding of alcohol units, as demonstrated 
through their consumption levels and higher exposure risk to alcohol (May and Gossage, 2011). This 
is corroborated by research which recognised that individuals tend to underestimate the alcohol content 
of different types of drinks when asked to accurately demonstrate a unit measure (Mukherjee et al., 
2013). This may partially explain the evidence that alcohol consumption is consistently and 







3.6 The alcohol industry and the power of advertising 
 
 
The role of the alcohol industry has been instrumental in perpetuating the female drinking culture by 
actively targeting women through advertising to maximise sales and profits. The changing roles of 
women in society since the mid-nineteenth century can be seen reflected in alcohol advertising 
(Figure1). The gender stereotypes range from the nurturing mother and dutiful housewife; to 
submissive sex object, liberated career woman flirting with feminism, to fun loving party girls and 
‘ladettes’ who could rival any of their male counterparts in the drinking stakes (Hastings, 2016; 
Atkinson et al., 2019; Institute of Alcohol Studies, 2020a). 
 




In recent decades, the alcohol industry has been quick to capitalise on the increasing prosperity of 
women because of improved gender equality in the workplace, developing marketing strategies 
intended to entice more women to spend their earnings on alcoholic beverages (European Centre for 
Monitoring Alcohol Marketing, 2008). The Institute of Alcohol Studies has estimated that the UK 





























(Institute of Alcohol Studies, 2020b). The alcohol industry marketing allocation for 2010 was assessed 
at £600m-£800m (All Party Parliamentary Group, 2015). In stark contrast, the Public Health England 
budget to assist adults and children affected by alcohol in 2018 was a mere £10.5 million (Public 
Health England, 2018). Empirical antenatal alcohol screening prevalence data can substantiate the 
need to address this issue as a public health emergency, preventing future disease, reducing disability 
and lowering mortality rates. 
 
This chapter has highlighted the complex relationship between women and alcohol. I have explored 
the perspectives of feminism and gender in socio-economic, political and cultural contexts. The 
contentious problem of women drinking in pregnancy can unjustly vilify mothers, but by 
contextualising the alcohol agenda within a post-modernist social and feminist framework we can 
begin to objectively explore and constructively address the issues raised. Recognition of the wider 
philosophical and epistemological paradigms and how they have influenced my subsequent research 















Chapter 4: Gaps in knowledge  
 
 
This chapter will provide an overview of antenatal alcohol screening practice, national governance and 
FASD service provision prior to my research, identifying the gaps in knowledge and service provision.  
 
4.1 Antenatal alcohol screening  
 
 
Antenatal screening is recommended by the WHO (2014) to facilitate the early identification and 
management of harmful drinking among pregnant women (WHO, 2014). Yet, alcohol drinking during 
pregnancy data are not routinely documented or audited. The limited evidence available was based on 
self-report and often unreliable because of poor estimation, poor recollection, the patient-clinician 
relationship, expected social norms and fear of perceived judgement (Walker et al., 2005; Lange et al., 
2014). As a result, maternal alcohol consumption levels are often significantly under-estimated. I have 
witnessed this in practice when delivering a pilot study of brief interventions for ‘risky drinking’ in 
pregnancy. A definitive evaluation was not feasible due to a lack of case identification via self-reported 
screening (Wilson, 2012). It concerned me greatly that the lack of documented, standardised and 
effective antenatal screening suggested that many women were not receiving the support they required, 
resulting in avoidable and continued exposure to alcohol harms.  
 
4.2 National governance and metrics 
 
The non-existence of national antenatal alcohol guidelines, recommended patient pathways and best 
practice standards, are testimony to the low priority afforded to alcohol use in pregnancy. Furthermore, 
alcohol data were either not obtained or not published by the national maternity governance 





Unit and the Perinatal Institute for maternal and child health. Finally, a dearth of published antenatal 
alcohol service evaluations or relevant audits in the UK invited investigation.  
 
4.3 FASD Service provision 
 
 
The Prescribed Specialised Services Advisory Group (2015) had considered a proposal for NHS 
England to commission a specialist FASD service but declined due to lack of incidence and prevalence 
data (Department of Health, 2015). They stated that without these data, they could not predict the 
potential number of FASD referrals per year. A paucity of PAE prevalence data undoubtedly 
contributed to this impasse.  
 
4.4 Problem statement  
 
 
The lack of PAE prevalence data and the need for an accurate and acceptable antenatal alcohol 
screening tool motivated and shaped my research. The unavailability of standardised maternity 
provision and the absence of any official governance and metrics, compelled me to examine these 
neglected areas. The collective knowledge omissions and service provision oversights initiated the 
genesis of my research endeavours. This thesis will set out how my coherent body of knowledge fills 
these gaps by contributing crucial new evidence supporting the progression to an antenatal alcohol 
screening programme that is fit for purpose in the UK.  A body of work designed to effectively prevent 






Chapter 5: Research aims and Methods  
 
The overarching aim was to explore the feasibility and clinical effectiveness of antenatal alcohol 
screening to clinicians, pregnant women and their partners. This culminated in a regional evaluation 
of antenatal alcohol service provision in maternity practice.  
 




The aim of study 1 was to evaluate the results of all relevant literature comparing the efficacy of 
combined blood biomarker analysis with maternal self-report, in the detection of alcohol exposure. 
This was to inform future research enquiry.  
 
Paper II. 
The aim of study II was to measure the prevalence of alcohol consumption in a North-East England 
NHS Trust, taken from a random sample of pregnant women in the first trimester, using blood 
biomarkers compared to self-report, and to ascertain the efficacy of both methods. This study also 
aimed to obtain empirical evidence to evaluate if routine antenatal alcohol screening was required.  
 
Paper III 
Study III aimed to reproduce the blood biomarker analysis in a random sample of pregnant women in 
the first trimester, in a second similar socio-economic NHS locality. This was to increase sample size, 
compare prevalence rates and review the validity and generalisability of the result. The second aim 






The aim of study IV was to evaluate risk awareness of drinking alcohol during pregnancy in pregnant 
women and their partners. The study also aimed to explore the acceptability of various alcohol 
screening methods to women and partners with the intention of informing future practice.  
 
Paper V 
Study V aimed to investigate health care professionals FASD knowledge and their attitudes to various 
methods of alcohol screening in pregnancy. This new evidence could then be used to address the 
knowledge gaps, guide future training strategy and inform practice recommendations.  
 
Paper VI 
Finally, study VI aimed to review current alcohol prevention, screening and treatment service 
provision in nine maternity Trusts across the North-East and North Cumbria (NENC). The aim was 
also to identify best practices and gaps in service to inform future recommendations for the Local 
Maternity System Transformational plan and implementation of the Better Births report across the 
region (National Maternity Review, 2016).  
 
5.2 Design, methods and participants   
 
 
This is a compilation thesis, comprising of six studies using a variety of data collection and analysis 
methodology. Fundamentally, the methodology selected was dictated by the research question (Grove, 
2013). Each study was designed to obtain the appropriate breadth and depth of data required to meet 
the research aims. To ensure the integrity and quality of evidence, the appropriate governance measures 





Table 1. Design, methods, and participants of studies I-VI 
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Study I. An initial literature review had highlighted the absence of a systematic review in this field 
and the need for a more methodical approach to critically appraise existing antenatal alcohol screening 
research was identified. A systematic review was conducted to compare the efficacy of blood analysis 
and maternal self-report in detecting at-risk women during pregnancy. This review investigated 
diagnostic accuracy. Study inclusion criteria considered whether: 1) the study was of pregnant women; 
2) the study compared self-reported alcohol consumption with analysis of biomarkers for alcohol in 
blood samples; 3) the study was of a sample taken from a community, hospital or clinic-based 
population; and 4) the study publication had a title and abstract in English available in the databases 
searched. Study exclusion criteria applied if a case-control design was employed or recruitment was 
restricted to participants who were known alcohol/drug abusers. The precise aim was to detect studies 
that screened for low or moderate alcohol consumption to identify women who may need help or 
support. The search timeframe included all publications until the 31st of August 2015. This systematic 
review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines (Moher et al., 2009) . The study was registered with the online database PROSPERO 
(CRD42015028051). The QUADAS II tool was used to evaluate the risk of bias and applicability of 
all studies included in the analysis (Whiting et al., 2011). The full methodology and quality appraisal 
can be found in Howlett et al (2017) (Howlett et al., 2017a). 
 
Study II. Building upon the findings from the systematic review, Study II was a prevalence study of 
pregnant women, using cross-sectional retrospective data from 2014 to 2015, comparing the 
prevalence of alcohol consumption in the first trimester of pregnancy using self-report and blood 
biomarker analysis. Northumbria Healthcare NHS Foundation Trust (NHCT) is one of the largest in 
England, covering a population of approximately 500,000. The area has a varied population ranging 





left a legacy of high levels of social deprivation and the poorest outcomes for alcohol related disease 
in England (ONS, 2016). A sample of 600 blood samples were taken from a booking population of 
2986 in 2014, equating to 20% of the population, ensuring a representative and reliable sample. An 
aliquot (0.5 mL serum/plasma) was tested of each anonymised blood sample for Carbohydrate 
Deficient Transferrin (CDT) and Gamma glutamyl transferase (GGT). CDT is a validated marker of 
binge drinking and sustained alcohol consumption in the general population, normalising 2–3 weeks 
from the start of abstinence. In the UK, CDT testing is commissioned by the government to assess 
alcohol abstinence in medics, pilots and banned motor vehicle drivers (Wolff et al., 2010).  
GGT is a liver enzyme which is elevated for eight weeks after the last exposure to alcohol. GGT is a 
cost-effective and highly sensitive marker for alcohol use in the general population, but is also 
increased in diabetes and obesity, with drug use and in cholestasis (Hock et al., 2005; Stoler et al., 
1998). The full cohort of 2993 booking appointments in 2015 were audited from the medical notes. 
The 2014 medical notes audit had to be abandoned as only 334 alcohol histories were recorded. The 
full methodology can be found in Howlett et al (2018), (Howlett et al., 2018).  
 
Study III. This was a prevalence study to identify first trimester alcohol intake in pregnancy, using 
cross-sectional retrospective data from 2015. Replicating the methods of Study II, six-hundred random 
blood samples taken at the antenatal booking appointment were anonymously analysed for the 
presence of CDT and GGT using a North Tees and Hartlepool NHS Foundation Trust (NTHFT) cohort 
(Howlett et al., 2020). NTHFT has a similar post-industrial, socio-economic profile of social 
deprivation and poor alcohol related disease outcomes (ONS, 2016). This study built a greater 
confidence in my earlier results by doubling the total sample size to one thousand two hundred. The 
blood biomarker analysis (Papers II & III) was assured by the National External Quality Assessment 





Study IV. This was a prospective survey of women and their partner’s attending antenatal clinics at 
NHCT during a 30-day period in 2015 (Howlett et al., 2017b). The women were the focus of this study 
as screening can only be beneficial if women feel comfortable with the methods used. I also included 
partner’s responses because it is documented that they are a significant influence upon women’s 
attitudes and behaviours (National Maternity Review, 2016). The survey questionnaire was designed 
and reviewed by an expert Multidisciplinary team panel and a PPI representative. The questionnaire 
was piloted in an antenatal clinic on a single day and as it was not modified further, the pilot data were 
included in the results. The survey document was universal for pregnant women and their partners and 
took 3–5 minutes to complete. Participants were asked to specify their role as a pregnant woman or 
partner, but anonymity was protected to encourage open and honest responses. The following questions 
were asked: 
1. What level of alcohol do you think is safe in pregnancy? (Nothing/1–2 units per week/1–2 units 
once or twice a week/more than 3 units per occasion). 
2a. In this pregnancy, which statement applies the most? (Stop drinking pre-pregnancy? /stop at the 
time your pregnancy was confirmed or suspected? /stop drinking after seeing midwife/still 
drinking/prefer not to say). 
2b. If you stopped drinking during pregnancy, how many weeks pregnant were you when you stopped 
drinking? (State number of weeks). 
3. Would you be happy to have your routine booking bloods tested for alcohol levels in a future 
pregnancy? (Yes/no). 
4. Would you be happy to have your baby’s first dirty nappy (meconium) tested? (Yes/no). 
Subjects were asked to expand on answers to questions 3 and 4 using free text. They were also asked 





Quantitative data were analysed using SPSS for Windows version 21 owing to its renowned precision 
and validity (IBM, 2021). Data were summarised using standard descriptive statistics (e.g., frequency, 
mean, median). Thematic analysis followed the six steps of Braun and Clark (2006) (Braun and Clark, 
2006) to ensure familiarisation with the free-text comments, every comment was read and re-read, then 
reviewed by another researcher to ensure accuracy and reliability. While reading over the comments, 
initial codes were produced through distinguishing features of the data. All relevant data were gathered 
through note writing. Once codes were developed, they were organised into potential themes. The 
relevant quotations were reviewed, and the final themes specified. 
 
Paper V. A cross-sectional national online survey conducted between October 2015 and July 2016 to 
ascertain healthcare professionals' (Midwives, Health Visitors, Obstetricians, Paediatricians and 
General Practitioners) perceived knowledge, attitudes and clinical practices concerning alcohol in 
pregnancy and FASD. Health care professionals are central to screening for alcohol use early in 
pregnancy, detecting alcohol exposed pregnancies and identifying women who require specialist 
support. Only a fraction of children with FASD are diagnosed in the UK, and this study aimed to 
investigate if a lack of awareness by NHS health professionals may be a contributing factor. Health 
Professionals were sent a web-link to the survey via email using a pragmatic cascade method of 
distribution which maximised the number of potential respondents but prevented the calculation of the 
numbers approached and the corresponding response rate.  
 
The study aims and data management processes were summarised in the introduction and all 
participants remained anonymous. The survey was piloted by representatives from each respondent 
group before general circulation to ensure clarity, validity and reliability (Ng, 2006). After feedback, 





to avoid compromising accuracy and consistency. Twenty four questions relating to perceived 
knowledge, attitudes, and clinical practices relating to alcohol in pregnancy and FASD were asked 
(Howlett et al., 2019). Data analysis was validated by the software package SPSS which is designed 
to provide accurate and validated results (IBM, 2021). Data were evaluated using standard summary 
statistics (e.g., mean, median, and frequency) and descriptive statistics facilitated the attainment of in-
depth information from respondents. Only valid responses are included, invalid reactions referred to 
unanswered questions or blank fields. Three answers were given which did not appear to respond to 
corresponding questions, deeming them invalid. Three researchers checked the data and unanimously 
agreed the answers invalid. All responses were verified by the co-authors to mitigate bias. 
 
 Paper VI. A cross-sectional study approach was adopted to undertake a service evaluation using the 
principles of survey methodology. This study was initiated when the North-East Local Maternity 
System (LMS) board assigned one of the seven priorities to improve maternal and infant health, to 
reducing alcohol consumption in pregnancy. This is derived from NHS England’s ‘Better Births’ 
strategy which aims to ensure that women receive safer, individualised care and greater informed 
choice and control to facilitate better outcomes (National Maternity Review, 2016). My growing 
reputation as an expert in this speciality was facilitated by my previous research portfolio, my original 
contributions to the field and expensive engagement in knowledge transfer strategies nationally and 
internationally. Therefore, I was commissioned to design a service evaluation survey to increase 
understanding of existing antenatal alcohol services and clinical practices across the nine maternity 
Trusts in the North-East and North Cumbria region, over a 2-month period in 2018.  
 
The key Stakeholders included heads of midwifery, local authority 0–19 Teams, Trust alcohol liaison 





survey in collaboration with local key experts in the field from Balance, the North East England 
Regional Alcohol Office, Durham Public Health and a fetal medicine consultant. The survey used 
closed and open-ended questions to quantify variables and capture exploratory findings, thus 
maximising the breadth and depth of findings. The survey included elements from a previous service 
provision data collection tool which had targeted leadership, commissioning, metrics, patient pathways 
and staff training. Data were systematically collected using the survey method face to face or in one 
instance via a telephone conference call. The detailed survey questions are documented in the 
publication (Howlett, 2020).  
 
Content analysis was the research method used to systematically interpret and code written text, 
converting qualitative information into quantitative data (Neuendorf, 2017). The volume of text was 
compressed into content classifications in accordance with coding protocols (Stemler, 2001). Each 
survey response was captured in a word document, then read and checked to ensure familiarity with 
the data. All locality data documents were then anonymised and numbered. Each document was 
transferred to an excel spread sheet, assigned a column and topics were duly established. Consequently, 
themes and sub-themes were produced and quantified, and the commonalities and differences noted. 
The data were then re-examined for accuracy. Basic categorisation, or coding was employed to 












This chapter will describe in more detail the methodology employed in my research. It will briefly 
evaluate epidemiology and prevalence studies, surveys and clinical audit. Finally, consideration will 
be given to ethics and the patient involvement. 
 
5.3.1. Epidemiology and Prevalence studies 
 
My studies can be categorised as non-experimental research, because they included observational and 
descriptive elements (Grove, 2013). Papers II and III can be described as epidemiological studies as 
they examined the patterns of health-related phenomena in a defined population. Epidemiological 
studies are essential to public health, and inform policy decisions and evidence-based practice by 
identifying risk factors for disease and targets for preventive healthcare (Bell, 2010).  
The prevalence studies utilised cross-sectional designs to obtain data from the pregnant population at 
risk of alcohol consumption. A snapshot of the population at risk, determines the extent to which the 
condition of interest is present (Bowling, 2009). The formula for Prevalence rate is, 
  
Number of cases with the condition or disease at a given point in time 
_________________________________________________________   = K 
              Number in the population at risk of being a case 
  
K is the number of people for whom the rate was established (e.g., per 100 population). Data were 
obtained from the sample. The denominator is the size of the sample and the numerator is the number 
of cases with the condition, at a given time as identified in the study. The quality of descriptive studies 
such as this, are more dependent on having a representative sample and high quality measuring 





5.3.2 Methodological Considerations 
 
 
Methodological problems can arise with potential for issues with reliability or validity e.g. the 
acquiescence response (saying yes to please the inquirer), evaluation anxiety, interviewer bias, mood 
of participant at the time, recall bias, etc., could arise in Papers II and IV (Babbie, 2013). Monk et al 
(2014) report that real-time reporting of drinking suggests higher levels of consumption than self-
reports based on recall (Monk, Heim and Price, 2014). This is attributed to recalled levels of 
consumption often involving a significant amount of guesswork and research on alcohol consumption 
has historically been over-reliant on retrospective self-reporting (Morleo et al., 2011). The self-
reported alcohol consumption in general population surveys appears to dramatically underestimate 
consumption. Ely et al (2009) attribute this to under-reporting and the low response rates in general 
population drinking surveys (Ely et al., 2009). They adopted the common assumption that under-
reporting affects heavier drinkers more than light drinkers because they are more likely to have poorer 
recall or because they are more likely to deliberately under-report their drinking from shame or guilt. 
Therefore, self-reported consumption may bias estimates of actual consumption levels, compromising 
the validity of the results if not acknowledged. Blaikie (1993) concurs that non-respondents may differ 
from respondents in some critical way, and this could skew the results (Blaikie, 1993). 
 
In response to these methodological concerns, I carefully considered the issues around self-reported 
data in relation to self-disclosure. I reviewed the current literature and incorporated the relevant 
findings and recommendations. Muggli et al (2015) conducted a study which aimed to identify the 
determinants which would enable women to provide accurate data in surveys of alcohol use in 
pregnancy (Muggli et al., 2015). They used focus groups in a public hospital in Australia with a total 





followed by a guided discussion. The findings showed that women’s emotional responses were 
generally positive, but they acknowledged the potential for anxiety and fear of judgement. 
Confidentiality and survey method, including a preference for methods other than face-to face, were 
also significant influences. Therefore, the questions rooted in clear context may reduce anxiety around 
questions about alcohol use in pregnancy (Muggli et al., 2015). They advocated methods using shorter 
recall periods, a list of drinks choices, measures of special occasion drinking and minimising complex 
and subjective language increase accurate self-report (Muggli et al., 2015). A setting perceived as 
confidential and anonymous may reduce the inclination to provide socially acceptable answers. The 
evidence is based on a study with a small sample size and may have cultural limitations which 
compromise reliability, but the conclusions do accord with other similar studies (Morleo et al., 2011; 
May and Gossage, 2011; Payne et al., 2005; Payne et al., 2014). This insight informed the scope of 
my research, influenced my survey methodology and led to further exploration of alcohol biomarkers.  
Finally, one significant advantage of survey was the effectiveness yet relative inexpense of production 
and administration (De Vaus, 2002).  
 
5.3.3 Clinical Audit 
 
 
Elements of clinical audit methodology were utilised in Papers II & VI because routine clinical data 
were easily accessible and very relevant to my research. The data I retrieved had never been utilised 
for clinical or research purposes before. Clinical audit involves a clinical performance assessment, 
resulting in refinement of clinical practice and the measurement of performance against agreed 
standards, forming a cyclical process of improving the quality of clinical care (NICE, 2002). Clinical 





5.3.4 Patient confidentiality 
 
 
From the antenatal booking notes, the patient hospital numbers and month of booking only were 
utilised to facilitate the research in Papers II & III, but confidentiality and data protection were 
meticulously adhered to. All data were managed according to standard NHS guidelines and ethical 
approval requirements.  
 
5.3.5 Ethical Issues 
 
 
The Integrated Research Application System (IRAS), a single online system for applying for 
permissions and approvals for health and social care research in the UK, was employed to coordinate 
all NHS research governance regulations. This study was given a favourable opinion by the Tyne and 
Wear South Research Ethics Committee (Ref: 15/NE/0216). NHCT and Northumbria University 
ethical and Caldicott protocols were adhered to throughout this study (NHS R&D Forum, 2014). The 
respondent’s right to confidentiality was respected and all legal requirements on data protection 
observed. The patients and clinicians were fully informed about the aims of the survey prior to 
participation. The surveys were designed to maintain anonymity and confidentiality and no personal 
identifiable details were requested or obtained. Implied consent was acquired by the respondents 
voluntarily returning the completed questionnaires in accordance with the Declaration of Helsinki 








5.3.6 Patient and Public Involvement (PPI) 
 
 
PPI has been integral to this research from inception to dissemination, demonstrating that the issue is 
important and relevant to the recipients of this research, i.e., women and FASD communities. The need 
for prevalence data about alcohol in pregnancy and FASD rates in the UK has been advocated by 
members of the FASD Network, represented by Maria Catterick, who advised in research planning 
meetings from Studies II-IV (Catterick, 2019). Likewise, birth mothers of children with FASD 
internationally have maintained a keen interest in this work and have kindly advised on the research 
content and survey questions of Studies II-IV, ensuring the integrity and validity of my research 
(Williams, 2019; Mitchell, 2019; NOFAS-UK, 2019).  
 
This chapter has showcased my expertise in applying a broad range of methodological and research 
approaches including epidemiology and prevalence studies, surveys and clinical audit. These have 
been used to inductively build a comprehensive picture of a relatively unknown area. Specifically, 
establishing prevalence data, examining effective alcohol screening tools and exploring the attitudes 
of both maternity service users and the health care providers. Staying true to my original aims, a key 
area has been the authentic involvement of those most affected by FASD, empowering them to shape 











Chapter 6: Results and Implications 
 
In this chapter, my six publications demonstrate my original contribution to knowledge as required in 
the award of a PhD (Phillips and Pugh, 2010). These publications illustrate how I have undertaken 
empirical work that had never been done before. I identified that a lack of FASD services could be 
traced back along the life-course to an absence of alcohol awareness and services in antenatal care, 
which if effectively addressed could prevent future harms of alcohol exposure. To evidence the extent 
of PAE I obtained regional antenatal alcohol prevalence rates for the first time. I investigated potential 
antenatal alcohol screening tools for the routine implementation into health services, from both service 
user and provider perspectives. Finally, I evaluated a regional antenatal alcohol service and from this 
gained novel data, synthesised new recommendations for service provision and clinical practice. I have 
incorporated a multidisciplinary approach to instigate systematic change to improve health outcomes 
for women and their children. In short, I am the first midwife in the UK to investigate the issue of 
alcohol in pregnancy from these perspectives and consequently I have contributed valuable new 
knowledge which is already informing national healthcare provision. 
 
Paper I: How strong is the evidence for using blood biomarkers alone to screen for alcohol 
consumption during pregnancy? A systematic review.  
 
The systematic review process increased my knowledge and understanding of current methods as I 
critically appraised the efficacy of self-report in relation to blood biomarkers. GGT was investigated 
in five studies, (Magnusson, Goransson and Heilig, 2005; Stoler et al., 1998; Savage et al., 2002; 
Larsson et al., 1983; Halperin et al., 1984) mean corpuscular volume (MCV) and phosphatidylethanol 





2002) and CDT, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and whole blood 
associated acetaldehyde assay (WBAA) were each investigated in two studies (Comasco et al., 2012; 
Magnusson, Goransson and Heilig, 2005; Stoler et al., 1998; Savage et al., 2002; Larsson et al., 1983). 
Although the methodological quality of all eight eligible studies was good, none of the biomarkers had 
both high sensitivity and specificity when compared to self-report. Evidence suggested that a 
combination of biomarkers, or combining biomarkers with self-report, increases accuracy. In 
conclusion, the blood biomarkers examined were of limited use in screening for low and moderate 
alcohol consumption in pregnancy when compared to self-report. Given the literature, many of the UK 
population of pregnant women would fall into this category of drinkers (Mukherjee et al., 2005; 
Mamluk et al., 2017; ONS, 2017). Therefore, certain biomarkers with higher detection rates of mild 
to moderate drinkers, such and CDT and PEth, may complement self-report and help improve the 
accuracy of diagnosis. In summary, I established that blood biomarkers and self-report both have 
strengths and limitations but the two combined may be a novel and robust antenatal alcohol screening 
approach that is feasible in practice. The impact of this could have significant implications for 
maternity services and the prevention of alcohol related harms including FASD. The findings from 
this systematic review have shaped the research questions of my subsequent publications by helping 
to clearly identify the potential of combining self-report with blood biomarkers in antenatal alcohol 
screening.  
 
Paper II: Assessing prevalence of alcohol consumption in early pregnancy: Self-report 
compared to blood biomarker analysis 
 
The percentage of women who reported consuming alcohol two months before pregnancy was 74.1% 





prevalence rate of 1.4% and GGT a prevalence rate of 3.5%. A statistically significant seasonal 
variation was noted, with months like December (Christmas) yielding higher values in both CDT & 
GGT. Further research in larger sub-samples would be useful to establish national antenatal alcohol 
prevalence data. If substantiated, this finding could inform national public health strategies, and 
maternity service provision. Although those with elevated CDT generally had high levels of GGT, 
only one person was positive for both CDT and GGT. Results from CDT analysis and self-report may 
underestimate prevalence in different ways. GGT appeared to lack specificity, but it may have value 
in supporting findings from CDT analysis. Blood biomarkers found a slightly higher level of alcohol 
consumption than was reported by the women, but the blood biomarkers used were sensitive to high 
level drinkers only.  
 
Further studies using additional blood biomarkers, such as Ethyl glucuronide (EtG) may be useful to 
detect recent lower-level alcohol consumption. I provided the first UK-based study to compare self-
reported alcohol consumption in the first trimester of pregnancy with data obtained from blood 
biomarker analysis, which contributes to the international body of evidence. This served to highlight 
the significance of the alcohol agenda in pregnancy in the UK and the need for routine screening in 
pregnancy. Furthermore, I identified that research combining blood biomarkers and self-report, may 
be beneficial in detecting an accurate alcohol drinking history in pregnancy. The wider impact being 
that these prevalence rates have been used by Public Health to inform new national antenatal alcohol 







Paper III: Assessing the prevalence of alcohol consumption in early pregnancy using blood 
biomarker analysis: A consistent pattern across North-East England? 
 
The NTHFT data revealed a CDT prevalence rate of 1.7% and a GGT prevalence rate of 4.2%. 
However, no overlapping cases were identified, and no significant correlation was demonstrated 
between levels for CDT or GGT (Spearman r = 0.06). These results support my earlier work and 
establish a more robust evidence base. Prevalence rates according to CDT and GGT analysis were 
comparable in both areas, suggesting similar patterns of sustained alcohol consumption in pregnancy 
across the region. Combining these data with those for (NHFT) gives a total prevalence estimate of 
1.6% (95% CI: 0.8–2.3) for the region. This is a significant step towards establishing a national picture.  
 
Paper IV: A survey of attitudes, beliefs and practice regarding alcohol use and screening in 
pregnancy: an opportunity for support and education? 
 
One-hundred and seventy-one pregnant women and 41 partners participated. Of the pregnant women, 
153 (89.5%) felt women should abstain from alcohol consumption, although only 70 (40.9%) reported 
not drinking in pregnancy. Of 96 women who reported drinking in pregnancy and reported when they 
stopped, all but six (6.3%) stopped drinking when they found out they were pregnant. Of women and 
partners who recorded an answer, 177 (87.2%) said they would consent to blood biomarker analysis. 
Confusion over safe levels of alcohol and using screening as an opportunity for education and support 
emerged as key themes from free-text responses. I determined that most parents want to be informed 
about any risks of harm to their baby including alcohol and most women were very positive about 
receiving extra screening interventions to identify alcohol consumption and actively requested more 





Nonetheless, I acknowledge that the acceptability of screening for alcohol in pregnancy in the small 
number of women who continue to drink is unclear due to the complex factors previously discussed. 
My work has already led to the effective implementation of antenatal alcohol screening by including 
service user’s perspectives which now reassures midwives and other professionals that women are 
receptive to questions pertaining to their drinking habits. This new evidence can support health care 
professionals, who may feel uncomfortable asking women about alcohol consumption. I have 
incorporated my findings into staff training packages, including the validated PH training collaboration 
which has been rolled out locally, regionally and nationally.   
 
Paper V: A survey of health care professionals’ knowledge and experience of Fetal Alcohol 
Spectrum Disorder (FASD) and alcohol use in pregnancy.  
 
There were 250 responses to the surveys (78 midwives, 60 health visitors, 55 obstetricians, 31 
paediatricians and 26 general practitioners). Of 51 midwives who had referred someone for alcohol 
use in pregnancy, 36 (70.6%) had referred to an alcohol specialist nurse and 42 (82.4%) to an 
obstetrician, 16 (31.4%) to addiction services and 18 (35.3%) to a social worker or child protection 
officer. Of 32 health visitors who had referred for alcohol use in pregnancy, 28 (87.5%) had referred 
to an alcohol specialist nurse, 4 (12.5%) to an obstetrician, 11 (34.4%) to addiction services, and 12 
(37.5%) to a social worker.  
 
Only 5 of 25 (20%) GPs would refer for any alcohol consumption in pregnancy, 8 (32%) if 
consumption was greater than 14 units per week, and 5 (20%) if greater than 21 units per week: whilst 
8 (32%) specified they would refer if the patient was visibly drunk at consultation. In total, 18 (58.1%) 





worried about stigmatisation initiated by diagnosis. The highest levels of FASD training were 
undertaken by 17 (54.8%) paediatricians, compared to only 17 (21.3%) midwives. This was mirrored 
in perceived knowledge levels; overall, only 49 (19.8%) respondents knew the estimated UK 
prevalence of FASD for example. These findings support my professional observations that UK 
clinicians urgently require training in alcohol screening in pregnancy and FASD generally to improve 
awareness, recognition and appropriate management of both issues.  
 
Paper VI: An antenatal alcohol service evaluation for the North East of England and North 
Cumbria.  
 
This service evaluation effectively reviewed the current maternity alcohol service provision, 
established the main themes to be addressed and guided the development of evidence-based 
recommendations. The traditionally overlooked issue of alcohol in pregnancy was afforded low priory 
throughout contemporary specialist maternity commissioning, guidelines and services. Inconsistencies 
were identified throughout regional clinical practices and service provision. For example, a variety of 
alcohol screening tools were employed with diverse thresholds for referral. A lack of standardised 
guidelines and patient pathways were partially attributed to varied local commissioning agreements. 
Limited professional knowledge and awareness was reflected in the fragmented access to training and 
was further compromised by the lack of UK specific FASD and alcohol consumption in pregnancy 
prevalence data.  
 
To address these deficits, research and health promotion programs were recommended to increase 
awareness, educate and prevent future alcohol harms. Innovative best practices identified in the region 





promotions; and Public Health led, protected-time mandatory training for all maternity staff. These 
initiatives facilitated delivery of high quality, effective and efficient patient-focused services. Data 
collection and documentation was sporadic and inconsistent, and governance was not common 
practice. Audit and monitoring were recommended for measuring and raising standards of care, driving 
the quality agenda and informing future planning of service provision. A standardised antenatal alcohol 
screening tool and an approved threshold of referral were also advocated. Standardised patient 
pathways involving effective alcohol screening and appropriate management processes incorporating 
best practice, were advised to facilitate referrals to easy-access, seamless alcohol services for pregnant 
women regardless of postcode. Implementation of these recommendations would necessitate 
appropriate leadership, commissioning and training strategies in order to successfully achieve the LMS 
objective of reducing alcohol in pregnancy. Despite my experience as Principal Investigator and study 
coordinator on earlier research, this paper is my first piece as sole author, illustrating how my journey 















Chapter 7: Discussion and Evaluation 
 
 
This chapter will detail the impact of my research. It will consider my contribution to the field of 
knowledge and the consequential implications for practice. As these findings are relevant to many 
clinical areas, I have compiled them into maternity services, primary care, secondary care and public 
health. The identified training needs will also be highlighted and finally, recommendations for future 
research will be recognised.     
 
7.1 Contribution to the field of study 
 
 
These articles represent an original and independent contribution to scholarship and have advanced 
my chosen field of study in several ways. I have presented and disseminated these findings which have 
added extensively to the current body of knowledge around UK antenatal alcohol screening in clinical 
practice. Significantly, I have examined the larger perspective of alcohol service provision in maternity 
care for the first time in North-East England and North Cumbria and synthesised evidence-based 
recommendations for clinical practice. My research findings have been disseminated at international 
conferences specialising in FASD, alcohol and substance abuse issues. (Appendix 1) 
 
7.2 Impact of my research 
 
 
When I embarked upon this research, I had not anticipated the opportunities that this work would have 
upon my professional and personal life. It is a particularly niche area and within a short period of time 
I was regarded a national expert on the area of PAE and FASD, specifically because I was a midwife 





this field has created a demand that offers a world of possibilities. Reflecting upon this developmental 
journey, I was surprised at how much I have achieved already but also realise how much still remains 
to be done. I have been very lucky that the close knit FASD community has been very supportive and 
motivating. My networking skills and resourcefulness have enabled me to maximise my prospects, 
fulfil my obligations and further this worthy cause. This coherent body of research has direct 
implications for antenatal alcohol service provision and the clinical practice for all healthcare 
professionals caring for pregnant women and their children.  
 
Antenatal screening for alcohol is vital to identify those women who require appropriate support and 
advice, and the process is deemed acceptable to women and their partners. The implementation of a 
screening programme also raises awareness whilst providing the opportunity to educate women and 
their families about the risks of alcohol harm. Pregnancy affords women the perfect opportunity and 
motivation to evaluate their health and lifestyle and make positive changes to benefit their entire life 
course. Health care professionals require the training and skills to deliver best practice. Importantly, 
effective antenatal alcohol screening also facilitates the identification of children at risk of FASD and 
expedites appropriate service referrals. My recommendations span many aspects of health provision 
and encompass maternity services, primary care, secondary care, public health and staff training. I 
have used the Research Impact Framework to demonstrate the four categories that assisted me to 









7.3 Recommended further research 
 
 
• Additional research on biomarkers such as EtG and PEth merit further investigation to ensure 
the most effective biomarkers are selected for alcohol screening to support self-report. Future 
studies could include consented blood analysis which would permit the identification of 
medical, demographic and lifestyle risk factors regarding alcohol consumption. Whilst 
acknowledging the risk of bias acquired through the procedure of consent, comparing 
anonymous and consented sampling may allow measurement of these biases.  
• Research examining the women’s viewpoint around their feelings and reactions to their 
realisation that they were drinking periconceptionally and the impact this has on their emotional 
and psychological wellbeing during and post-pregnancy would be a very interesting 
progression of my work. The role of the midwife and other healthcare professionals in this is 
also worthy of further exploration.   
• Pilot-testing a screening programme and interviewing women to evaluate the effectiveness and 
acceptability would further inform the introduction of a national antenatal alcohol screening 
programme.  
• Meconium testing is known to be a very reliable method to inform retrospective alcohol 
consumption behaviours in the 2nd and 3rd trimester of pregnancy (Pichini et al., 2012; Lange 
et al., 2014). A meconium testing study in South West Scotland found that over 15% of 
pregnant women were drinking substantial amounts of alcohol and only 1% declined to 
participate (Abernethy et al., 2018). Research using an English cohort would bolster this work 
and benefit early FASD diagnosis and intervention. Furthermore, these data could help prevent 





• During my international networking, birth mothers of children with FASD have expressed a 
general deficit of evidence from their perspective. Some women have specifically requested 
research into their personal challenges of coping with addiction whilst raising a child with 
FASD throughout the life course. As previously verified, resourcing FASD research remains 
challenging. In the absence of a dedicated funding stream, progress is slow and problematic. 
FASD remains largely unacknowledged in the UK compared to similar neuro-behavioural 
congenital problems such as autistic spectrum disorder. A change in awareness around fetal 
alcohol harm and a more joined-up working and information exchange when developing care 
pathways is required. I am hopeful that the commissioners and providers can work 
collaboratively to make a positive difference to the lives of the children and young people 
living daily with fetal alcohol related harm. I continue to advocate for Alcohol and FASD 

















Chapter 8: My personal Journey 
 
 
In this chapter, I will reflect upon the professional and personal impact of my research experience and 
give an account of the successes, challenges and limitations I have encountered, also contemplating 
how they have contributed to my knowledge, skills and competencies as a clinical academic researcher.  
 
8.1 Professional Context 
 
 
My professional background, experience and knowledge had huge benefits to understanding women 
who access maternity care. Working in the NHS, in antenatal services and as a midwife meant I was 
an accepted part of the team which helped to establish clinical and research networks of support. This 
‘insider’ role had both advantages and disadvantages; access to patient sensitive data within a 
professional code of conduct is contrasted to the risk of role conflict and the need to prioritise other 
important duties and obligations. As an experienced clinical trials nurse and midwife, I have many 
research skills, contacts and project management expertise to efficiently and effectively run my studies 
to time and target. The support I received from my R&D department for example was invaluable when 
navigating the ethics and research governance processes.  
My research continues to be aligned to the Nursing and Midwifery Council (NMC) standard ‘Prioritise 
People’, a value applicable throughout my professional scope of practice which includes direct care, 
leadership, education and research (NMC, 2018).  
From a strategic perspective, my work also resonates with the NHS long term plan. Salient points 
include ‘doing things differently’, which advocates professional collaboration and partnership working 





and integrated care systems. PAE and FASD falls precisely into the preventing illness and tackling 
health inequalities objective which aims to tackle some of the most significant causes of ill health, 
including alcohol (NHSEngland, 2019). Ensuring the ‘Best start in life for all’, which include the 
objectives to reduce stillbirth and premature births, can benefit directly from a reduction in PAE 
(Public Health England, 2016a). Finally, my work directly impacted upon the implementation of the 
‘Better Births’ recommendations by informing the local LMS priority to reduce alcohol in pregnancy 
(National Maternity Review, 2016).  
Leading this research and changing clinical practice has involved developing my quality improvement 
expertise and applying my compassionate and inclusive leadership skills (National Improvement and 
Leadership Development Board, 2016). In undertaking the process of applying the new knowledge 
acquired to improve the health outcomes of mothers and their children, my work could be described 
as translational research (Haby et al., 2016).   
 
8.2 Challenges  
 
 
Initially as part of my professional development I had negotiated a modest amount of protected study 
time to conduct this research and disseminate the findings. Unfortunately, the department experienced 
a restructure and this support was no longer available. Working full time without allocated study time 
was demanding but not insurmountable. I have employed my seasoned skills of time management, 
prioritisation and tenacity to complete this project.   
 
The lack of funding from day one has been challenging. The timelines dictated by conventional funding 





the health agenda, and in many ways this research is still regarded as avant-garde. Inevitably, funds 
were only allocated to predetermined health needs to meet obligations ensuring the accountability of 
the finite resources available. Epidemiological prevalence studies are particularly difficult to finance 
because organisations such as the NIHR have narrow remits which usually only fund interventional 
research which can be translated directly into practice, again to demonstrate financial accountability. 
 
An interesting reflection of note was the lack of midwifery journals interested in publishing my work. 
The only professionally aligned publication was in the Journal of Research in Nursing, and most of 
the other journals were European or American based. This mirrors my observations of the significance 
attributed to PAE and FASD within the midwifery profession and across the UK generally. 
 
I am defined by Myres-Briggs as an Introverted, Intuitive, Feeling and Judging (INFJ) personality, 
known as the ‘Advocate’ (Myres Briggs, 2017). This assessment was accurate, beneficial and 
increased my general self-awareness on a personal and professional level. As an introverted personality 
type, I found public speaking at conferences intimidating. However, with repeated exposure, 
desensitisation and positive feedback, I now feel more comfortable in the role as my confidence has 
increased to the point where I now actually enjoy the chance to increase awareness in my quest to 





I was generously awarded capacity building funding from my Trust R&D department which allowed 
me a small budget to finance the blood analysis using CDT and GGT. However, this was not my 





the additional blood biomarker EtG. EtG is a sensitive test which can detect low levels of alcohol 
consumed up to three days previously (Kilburn et al., 2015). It can identify the more common, low 
level and occasional drinkers who may be unaware of the risks of alcohol exposure to their baby but 
is considerably more expensive to analyse. EtG results would have added even greater value to my 
findings and possibly given more accurate prevalence rate data to better inform practice. Therefore, I 
adopted a pragmatic and flexible approach, downscaling my research to meet financial constraints. 
Nonetheless, the original plan is merely postponed to a later study. The data I have collected thus far 
will strengthen future funding bids and evidences the need for further research in this area.  
 
In summary, I have thrived personally and professionally under the stimulating environs of this PhD. 
I have a clearer understanding of professional practice issues, clinical and research governance and 
current NIHR and NHS imperatives. I have established significant networks through my personal 
research. I also collaborate with key regional and national stakeholders such as the NIHR CRN, NHS 
partner organisations and universities, contributing to a collaborative strategic vision for research and 
innovation in practice.  
 
When I first embarked on these research assignments, I anticipated challenges and hoped to gain new 
knowledge, skill sets and expertise in research and the specialism of PAE and FASD. My expectations 
have been exceeded and yet I am acutely aware of how much I still need to learn. Moreover, I had not 
anticipated the diverse, exciting and rewarding experiences that were also part of this rich and complex 
voyage of self-discovery. On reflection, I believe that PhD by publication was the appropriate route 
for me to obtain a doctorate qualification as I was keen to publish the evidence to expedite change in 
this sphere of clinical practice and service provision. Like funding applications and ethical approval, 





many processes of governance and publication are out of the researcher’s control and therefore 
patience, acceptance and resilience are essential qualities. Feedback from reviewers has generally been 
insightful, constructive and undeniably improved the quality of my writing and my competency as an 




This submission for PhD by publication has demonstrated a body of work providing evidence of an 
independent and original contribution to the knowledge and understanding around FASD prevention 
in the form of antenatal alcohol screening. This experience has allowed me the opportunity to 
undertake innovative research and develop professionally as both nurse and midwife researcher. I have 
developed my knowledge skills and expertise to the extent where I now receive invitations to provide 
specialist consultancy opportunities across a range of services nationally. My studies are already 
informing health policy, further research and clinical practice in the UK and are internationally 
relevant. Pursuing this body of work has allowed me to network internationally at conferences with 
inspirational international experts in the field. Due to the complex and far-reaching implications of 
FASD and alcohol in society, I now have an entire future career of research opportunities to pursue 
and the burgeoning research skills and strategies required to achieve them. My progress is eloquently 
articulated by Sir Winston Churchill, ‘This is not the end. It is not even the beginning of the end. But 
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10.1 Appendix 1: Knowledge transfer strategies  
 
• Poster at Research and Development Forum2021, postponed from 2020. 
‘Seven NIHR Senior Nursing & Midwifery Research Leaders based in the 
North East of England: The story so far.’ Successful poster application 
illustrating our collective work aiming to embed research in clinical 
practice.  https://annualrdforum.org.uk/   
 
• First UKFASD Research Collaboration held in Manchester 4th-5th April 2019 
to establish a UK research strategy across the life course. I was invited on 
the strength of my work which had been shared at previous conferences, 
especially EUFASD.  Our first collaborative paper Fetal Alcohol Spectrum 
Disorders– an overview of current evidence and activities in the UK, has 
been accepted for publication. 
 
• Society for the Study of Addictions. Newcastle 7th-9th November 2018 
‘Exploring the feasibility and clinical effectiveness of antenatal alcohol 
screening to clinicians, pregnant women and their partners.’ Presentation 
& Poster (Won best student poster award). Awarded NHCT R&D 
department grant. Successful application which has showcased my work 
and facilitated networking and collaborative work. I now have an invitation 





• Public Health & Local Maternity System conference. Durham 15th October 
2018. Alcohol in pregnancy. What’s happening in our region? I was invited 
as a guest speaker to present the findings from my service evaluation 
project which was published in paper 6. This informed future service 
provision and identified the need for standardised antenatal alcohol 
screening and service provision across the region, guiding the alcohol work 
stream which it initiated.  
 
• EUFASD BERLIN 24th -26th September 2018. ‘Alcohol screening in 
pregnancy: an opportunity for support and education?’ poster, & ‘A survey 
of health care professionals’ knowledge and experience of Fetal Alcohol 





Successful application and awarded NHCT R&D department grant. This 
event is the highlight of the FASD calendar and provides the opportunity to 
share new research, initiatives, network and collaborate internationally. 
This is useful to ensure a coordinated approach to research strategy, 
avoiding unnecessarily duplication and to develop existing research 
projects.   https://eufasd.org/pdf/Program_book_EUFASD2018.pdf  
 
• Helena Biosciences IUGM Krakow, 19th-21st September 2018. Sponsored 
by Helena Biosciences. ‘Prevalence survey of alcohol consumption at 
antenatal booking in pregnancy: Comparing blood biomarker analysis to 
self-report- An update’. Helena Biosciences had funded the first two years 
of my Professional Doctorate, so they invited me as a guest speaker to 
showcase my research and to illustrate how they were supporting my work 
which aimed to improve patient outcomes. This provided good insight into 
the mutual benefits of collaborating with industry. I maintain a good 
relationship with the company today and update them regularly on my 
progress.  
 
• Best Start in Life: The Impact of Alcohol on Childhood. Arranged by Public 
Health and Balance. 6th December 2017. Durham. ‘FASD and alcohol in 
pregnancy’ presentation. This regional conference was a launch event to 
raise awareness around all aspects of alcohol in childhood. I was invited as 
a guest speaker by Balance due to my growing reputation as an expert in 
FASD and alcohol in pregnancy. 
 
• Society for the Study of Addiction (SSA) 2017: Newcastle 8-9th November 
2017. ‘Assessing prevalence of alcohol consumption in early pregnancy: 
Self-report compared to blood biomarker analysis.’ Successful poster 
application. Awarded NHCT R&D department grant. I have been 
encouraged by the society to apply for a post-doctorate fellowship as non-





• Kettil Bruun Society 2017: Sheffield Alcohol Research Group at ScHARR at 
the University of Sheffield. 5-9 June 2017. ‘Assessing prevalence of alcohol 
consumption in early pregnancy: Self-report compared to blood 
biomarker analysis’ Guest speaker presentation. Successfully applied and 
was awarded NHCT R&D department grant. This raised my awareness of 









• Vancouver 7th International Conference on Fetal Alcohol Spectrum 
Disorder – Research: Results and Relevance 2017. 1-4th March 2017. 
‘Alcohol Screening in Pregnancy: An Opportunity for Support and 
Education?’ Successful application to submit poster & abstract which is 
published on their website. Awarded travel grant of £500 from 
Northumbria University and Helena Biosciences. To attend an 
international conference was a privilege which allowed collaboration with 
global stakeholders, particularly the FASD birth mothers who have 
requested more research from their viewpoint. I have established good 
links with these women who have kindly advised and assisted with my 
research projects so far. 
https://interprofessional.ubc.ca/files/2016/06/FASD2017_brochure.pdf  
 
• Northumbria Healthcare NHS Trust Nursing Conference, Newcastle – 9th 
November 2016. ‘Alcohol screening in pregnancy: an opportunity for 
support and education?’ Poster & ‘Dispelling the Myths of Research’ 
clinical trials workshop. I was invited to submit the poster and as a guest 
speaker to deliver a teaching session encouraging clinical research 
engagement in practice, as my role at that time was Senior Research Nurse 
and Midwife in the Trust.  
 
• Stirling university Alcohol and Pregnancy research seminar. 1st November 
2016. I was invited to present ‘Screening for Alcohol Consumption in 
Pregnancy’ by a colleague from Newcastle University. I was awarded NHCT 
R&D department grant. This was a valuable conference because we met as 
a group of representatives from all countries in the UK to scope and 
coordinate research plans to ensure they would complement one another 
rather than compete. This was helpful because I met Tappin and Mactier, 
researchers from the pilot study upon which my second paper was based.  
They have since published a meconium study set in South West Scotland 
which I had planned for England. However, an English cohort would 
provide a comparison and contribute overall to these findings. The North 
East region’s drinking patterns are the highest in England and very similar 
to those in Scotland.  







• Helena Biosciences Royal Society for Medicine. London. 6th October 2016. 
‘Prevalence survey of alcohol consumption at antenatal booking in 
pregnancy; comparing blood biomarker analysis to self-report.’ I was 
invited to present my research findings for paper 2 as Helena Biosciences 
had analysed my blood samples using their Clinical Capillary 
Electrophoresis assay. This exhibited our partnership working to other 
international researchers and clinicians.  
 
• EUFASD conference London: 12-14 September 2016. ‘Prevalence survey of 
alcohol consumption at antenatal booking in pregnancy; comparing blood 
biomarker analysis to self-report.’ Successful application as guest speaker. 
‘Alcohol screening in pregnancy: an opportunity for support and 
education?’ Successfully applied to present a poster, both abstracts 
published in EUFASD database. I was awarded a NHCT R&D department 
grant. This was my first national conference where I began my journey of 
presenting to a large audience of experts. It was a great opportunity to hear 
other experts in the field and recontextualise my work within the identified 
gaps in knowledge informed by international issues. Many of these 
individuals I now work alongside as equals. The lack of acknowledgement 
of FASD and alcohol in pregnancy in the UK was stark in 2016. The 
progress and momentum we have gained over the last few years through 


















10.2 Appendix 2: Impact of research  
I. Research-related impacts 
Research networks 
• I am a co-investigator on a National Institute for Health Research (NIHR) Research for Patient 
Benefit Programme (RfPB): CHAMPION - AlCohol HArM PreventIOn iN pregnancy study. 
https://fundingawards.nihr.ac.uk/award/NIHR201128 Research question: What are the 
components of an implementation intervention to support midwives’ provision of 
recommended care addressing alcohol consumption with women attending antenatal 
appointments; is such an intervention feasible to implement in practice; and is it acceptable to 
service providers and service users? The intended impact of this is to design and provide a 
nationally recognised, evidence based best practice training programme for midwives.  
• I am a founding member of the UKFASD Research Collaboration. We are the leading experts 
in FASD and PAE in the UK working to provide a coordinated research strategy by identifying 
and prioritising areas in most need. A key impact is the recent citation in the Commission on 
Alcohol Harm and published ‘Fetal Alcohol Spectrum Disorders– an overview on current 
evidence and activities in the UK’ (The Commission on Alcohol Harm, 2020; Schölin et al., 
2021). Building on my work, I plan to undertake a national alcohol in pregnancy prevalence 
study to compare regions, with the potential of targeting problem areas. I am also supporting 
the Irish FASD advisory group with their work in a consultancy capacity. 
• Within my post as Senior Lecturer in Midwifery at Northumbria University, I pursue my 
research interests further and continue to share this knowledge with the next generation of 
health care professionals so that they can ensure appropriate care and recognition is provided 





status on behalf of the university, and I am one of only 38 REF standard researchers in the 
Nursing, Midwifery and Health department.  
• In addition, I act as second supervisor to two PhD students and a medical student who are 
replicating my survey instrument from Paper V: A survey of health care professionals’ 
knowledge and experience of Fetal Alcohol Spectrum Disorder (FASD) and alcohol use in 
pregnancy. In an initiative to build upon the established knowledge base, I plan to evaluate 
and compare these new findings from each student’s respective Scottish, American and Irish 
cohorts. 
Leadership and awards 
• In 2019 I was awarded the prestigious 70@70 Research Nurse and Midwife Leadership award 
to promote research in clinical practice across all specialities within the NHS. This has helped 
raise my research profile and has increased my fundability, adding further credibility to 
midwifery-led research in a currently medically focused hegemony.  
• I have also been awarded The Green Shoots scheme funding from the Clinical Research 
Network (CRN) in recognition of my work as a Principal Investigator. This funding enabled 
me to gain further specialist training and present two posters to EUFASD BERLIN 24th-26th 
September 2018, helping to raise international awareness and enabling me to connect with 
researcher networks globally. 
• I attended the Society for the Study of Addiction (SSA) conference in Newcastle 2018 and won 
the best student poster award for my unique research around alcohol in pregnancy and raising 





• My growing reputation for expertise in the field nationally and internationally has led to 
invitations to peer-review bids and publications for organisations including the NIHR RfPB, 
the Journal of Nursing in Practice and Addiction.  
 
II. Policy impacts 
• My work is cited globally and has been referenced in the national PHE document: Maternity 
high impact area: Reducing the incidence of harms caused by alcohol in pregnancy (Public 
Health England, 2020). 
• As a registered member for the advisory panel for NICE, supporting health and social policy 
improvements regarding the risks of alcohol in pregnancy, prevention and training around 
FASD. I have advised the NICE FASD consultation to implement the evidence-based service 
provision and clinical practice recommendations from Paper VI. A standardised pathway and 
service will promote clarity and equity of provision, and could even reduce the risk of confusion 
and error when doctors and other staff rotate to different localities thus improving care quality 
and patient experience. The mobilisation of support provided by my research findings adds to 
the growing political capital, bringing about a sea change of attitude and ultimately driving 
policy change.   
 
III. Service impacts: health and intersectoral  
• I provide guidance and training to Northumbria Healthcare NHS Trust, the regional maternity 
network and now Northumbria University to raise awareness and change clinical practice in 
relation to alcohol in pregnancy and FASD to promote evidence-based practice. 
• I advise and support Public Health Durham on the Regional Alcohol in Pregnancy Working 
Group after scoping the Local Maternity Service (LMS) priority for alcohol across the region. 





to improve practice and quality of care across the region. A coordinated antenatal alcohol 
screening programme was an identified requirement from my service evaluation (Paper VI). 
NHS Ayrshire and Arran have designed an effective FASD and alcohol service based on a 
Canadian model. (NHS Ayrshire and Arran, 2019). From my networking activities, I 
established links with the team and have begun to adapt and implement elements of the service 
in collaboration with the North-East LMS. I have co-designed and piloted an evidence-based 







• My research (Paper I & II) identified that self-report only detected a minority of women who 
drank in pregnancy. I observed that none of the internationally recognised alcohol screening 
tools were specifically designed for a pregnant population. On merit, AUDIT C was the 
regionally adopted maternity screening tool. To maximise detection in a pregnant cohort, I 
initiated the design of a bespoke antenatal alcohol screening tool based on the adapted Audit 
C, which crucially asks women about pre-pregnancy drinking habits which can then help 
identify those at risk in pregnancy. It has been commended by PHE Maternity Transformation 
Programme Prevention for improving quality of care and has been shared as a nationally 






• Advisor to the  Alcohol Development Group at Northumbria Healthcare NHS Trust who meet 
regularly to share good practice and new developments in patient care. I also sit on the North-
east Alcohol Network to plan and implement regional alcohol strategy with key stakeholders 
to share evidence-based practices and improve quality of care to all. 
• Liaison with the manufacturers of pregnancy testing kits and pregnancy specific vitamin 
supplements to request that they advise women to abstain from alcohol for the duration of their 
pregnancy as they are both predominantly accessed during preconception or early pregnancy. 
I concluded that this would be a good resource to utilise, combining health and industry with a 
shared goal of improving health outcomes.  
• Redesign of the Patient Administration System (PAS) booking form for all antenatal booking 
appointments in NHCT to facilitate robust, research-based alcohol documentation to assist 





• In accordance with the ‘Making Every Contact Count’ initiative, my research evidence from 
Paper VI advocates routine alcohol screening for all women of childbearing age in primary 
care settings, with an emphasis on preconception health advice and contraceptive counselling 
(Public Health England, 2019). This research also recommends referrals to substance misuse 
interventions for all women identified to have an alcohol use disorder as good practice to 
prevent future harms. These implementations are currently under review with my colleagues 
in Public Health and Balance to improve quality of care and patient outcomes.  
• There is an expressed need for FASD service provision with routine standardised referral 
pathways. As a result of my special interest in PAE prevalence rates and the prevention of 
FASD from a midwifery perspective, I am part of a regional multidisciplinary strategy group 
which is establishing routine standardised evidence-based diagnostic criteria and management 
programmes in the UK. Increasing the efficacy, availability and accessibility of these services 
will benefit individuals and their families by mitigating the impact FASD and improving their 
quality of life.    
• Paper V highlights the need for a FASD pre-registration training for all professions including 
health, social work and education to provide the knowledge, skills and confidence for practice. 
A universal FASD training programme for health professionals incorporated into continuous 
professional development and competency frameworks is also recommended to maintain 
evidence-based knowledge and practice. I have a significant demand by reputation for my 
training delivery across the professional disciplines. I have been intrinsic to the design and 
delivery of the LMS training package which is based on my research and resources, and meet 
the objectives of the Better Births directive which aims to minimise health inequalities and 








IV. Societal impacts 
Knowledge, attitudes and behaviour 
• My research promotes UK public health directed alcohol in pregnancy and FASD awareness 
campaigns based on the successful Canada and Australia initiatives (Poole and Public Health 
Agency of Canada., 2008; Commonwealth Government of Australia, 2018). These initiatives 
contribute to the alcohol and FASD agenda promoted by local public health, Balance and 
FASD network stakeholders of which I am a part. My research has recently been cited by PHE 
in Maternity high impact area: Reducing the incidence of harms caused by alcohol in pregnancy 
(Public Health England, 2020). This document will undoubtedly lead to changes in knowledge, 
attitudes and behaviour of health care professionals and the general public.  
• In collaboration with regional, national and international networks, I lead on the local Trust 
FASD Awareness day every year on the 9th of September which informs and educates the 
public, local maternity services and other stakeholders using a research-rich strategic and 
inclusive approach. This involves coordinated activities such as managing stalls in the 
reception area of hospitals, writing NHS Communication Team staff bulletins, designing Trust-
wide FASD screen savers and speaking to the media. This campaign provides an effective 
vehicle of dissemination and praxis for my body of research findings and recommendations 
with the objective of improving the health status at a population level. 
http://www.chroniclelive.co.uk/news/health/durham-mum-tells-how-adopted-10012415 
• Working closely with the FASD Network and the UK & European Birth Mother Network to 





and professionals. This collaboration promotes social capital and empowerment for this issue 
and these women affected. My research findings can also be argued to promote health equity 
and human rights by providing individuals with the vital information they require to make fully 
informed decisions that will affect their health and wellbeing. 
• Collaboration with Balance, the local North-East alcohol office to contribute to a public health 
awareness campaign to prevent alcohol related harm to future generations. I presented an 
overview of FASD and a summary of my studies at the Balance conference ‘Best start in life- 
alcohol and childhood’, 06th December 2017. This knowledge exchange promotes health 
literacy in the community allowing individuals to make informed choices and on a larger scale, 
influences health and social care organisations to prioritise relevant public health strategies. 
My research into PAE and FASD therefore endorses sustainable development whereby people 
are able to meet their basic needs and experience a good quality of life without compromising 
the health and wellbeing of future generations (Kuruvilla et al., 2006). 
• Consultation with the media to give statements about FASD and clarify the best practice 
recommendation to avoid alcohol in pregnancy and raise awareness. This provides social 
capital for change and empowers women and their families to make informed decisions about 
their health.  
Culture and art 
• In my capacity as Research Midwife and FASD champion, I have contacted the main soap 
operas and popular television programmes such as ‘Hollyoaks’ whose target audience is young 
people of reproductive ages to include FASD story lines. I have had positive responses from 
directors and producers and the BBC radio programme ‘The Archers’ has recently introduced 





have been used to educate targeted audiences in the past. One original example is when Grange 
Hill joined the ‘Just say no’ to drugs campaign in the 1980s which significantly impacted upon 
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